The Vilcek Foundation was established in 2000 by Jan and Marica Vilcek, immigrants from the former Czechoslovakia. The Foundation was established with the aim of raising public awareness around immigrants’ contributions to the sciences, arts, and culture in the United States. The Foundation’s mission was inspired by the couple’s careers in science and art, as well as their personal experiences and appreciation for the opportunities given to them as newcomers to the United States.
User loginNavigationSyndicate |
fuad el-hibriEmergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors
ROCKVILLE, Md., Jun 13, 2011 (BUSINESS WIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that its Chairman and Chief Executive Officer, Fuad El-Hibri, has been appointed to serve on the Board of Directors of the U.S. Chamber of Commerce. The U.S.
Submitted by admin on Mon, 06/20/2011 - 13:28. categories [ ]
Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation
Submitted by admin on Fri, 06/10/2011 - 13:57. categories [ ]
Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule
ROCKVILLE, Md., May 31, 2011 (BUSINESS WIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that eight lots of BioThrax(R) (Anthrax Vaccine Adsorbed) have received regulatory release for delivery to the U.S.
Submitted by admin on Tue, 06/07/2011 - 15:20. categories [ ]
Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference
Submitted by admin on Wed, 06/01/2011 - 13:45. categories [ ]
Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine CongressROCKVILLE, Md., Apr 12, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that Fuad El-Hibri, its chairman and chief executive officer, has been recognized as Biotech CEO of the Year during the Vaccine Industry Excellence (ViE) Awards at the World Vaccine Congress.
Submitted by admin on Fri, 04/15/2011 - 12:08. categories [ ]
Emergent BioSolutions to Present Today at Needham & Company Healthcare ConferenceEmergent BioSolutions Inc. (NYSE: EBS) will be webcasting its presentation at the 10th Annual Needham & Company Healthcare Conference in New York on Tuesday, April 5, 2011 at 8:00 AM Eastern. During the presentation, a member of the company’s senior management team will provide a corporate overview, which may include a discussion of recent business developments, 2010 financial results and financial guidance for 2011.
Submitted by admin on Tue, 04/05/2011 - 11:27. categories [ ]
Emergent BioSolutions Observes World TB Day Launches “OETC: Endeavor to End Tuberculosis,” a video to raise public awareness ofROCKVILLE, Md., Mar 24, 2011 (BUSINESS WIRE) — Emergent BioSolutions Inc. (NYSE:EBS) today released the following statement in observance of World TB Day.
Submitted by admin on Fri, 03/25/2011 - 17:34. categories [ ]
Emergent BioSolutions Presents Positive Data from Its TRU-016 Program at American Society of Hematology MeetingROCKVILLE, Md., Dec 06, 2010 (BUSINESS WIRE) –
Submitted by admin on Wed, 12/15/2010 - 07:17. categories [ ]
Fuad El-Hibri Recognized by Vilcek Foundation
Submitted by admin on Fri, 12/10/2010 - 16:54. categories [ ]
Fuad El-Hibri and the International Biomedical Research AllianceThe International Biomedical Research Alliance (IBRA) is a philanthropic organization that is dedicated to the support of the NIH-Oxford-Cambridge Scholars Program, which strives to establish the highest standards of excellence in training biomedical researchers, advance groundbreaking biomedical research, enrich the pool of leaders in the field, and eliminate barriers which frustrate the transfer of a broad spectrum of knowledge to the next generation of researchers.
Submitted by admin on Sat, 11/13/2010 - 11:43. categories [ ]
|
Category CloudTag CloudWho's new
Who's onlineThere are currently 0 users and 2 guests online.
|